The U.S. Food and Drug Administration is likely to approve maraviroc, a novel drug that targets the cells of HIV-infected patients and not the virus itself.

Manufactured by Pfizer, the drug received a unanimous vote from 12 health advisers to sell under the brand name Celsentri. It would represent the first so-called CCR5 receptor antagonist to be sold

Researchers at the University of Washington School of Medicine in Seattle have found exactly how human immunodeficiency virus-1 (HIV) enters into women's bodies during sex. The study also identified HIV's first target cells in vagina.

"The majority of HIV-1 infected individuals worldwide are women who acquire HIV infection following sexual contact. Blocking HIV transmission and local spread in the female lower genital tract is key to prevent infection and ultimately to ease the pandemic," described study's authors Dr. Florian Hladik and Dr. M. Juliana McElrath

A new study found that gorillas tested in Africa have Simian Immunodeficiency Virus (SIV), which is a form of the Human Immunodeficiency Virus (HIV) that causes AIDS. The AIDS-causing virus, HIV was originally found in chimpanzees and humans.

The lead author of a recent article in November's issue of the scientific journal Nature reports that researchers surprisingly found that these gorillas are infected with SIV, which is closely related to HIV. The scientists believe that the chimps may have been the transmitter of the virus to the gorilla species, but they're not certain as to how

Researchers from the Duke University have developed a computer model that can predict the effectiveness of various microbicidal recipes in destroying human immunodeficiency virus (HIV) before it reaches vulnerable body tissues.

By the help of Computer tool, the researchers have determined that a thin, long-lasting coating of microbicide delivered to susceptible tissues in a woman's vagina can significantly reduce the spread of HIV

Researchers from the Université de Montréal have claimed a strategic breakthrough in fighting the AIDS virus i.e. human immunodeficiency virus (HIV).

Researchers have claimed the identification of a new therapeutic target that restores the function of the T cells whose role is to eliminate cells infected with the virus. This constitutes a major breakthrough, opening new prospects for the development of therapeutic strategies for controlling HIV infection